These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 11895980)

  • 21. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.
    Xu Y; Kodner C; Coleman L; Johnson RC
    Infect Immun; 1996 Sep; 64(9):3870-6. PubMed ID: 8751941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing.
    Qiu WG; Schutzer SE; Bruno JF; Attie O; Xu Y; Dunn JJ; Fraser CM; Casjens SR; Luft BJ
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14150-5. PubMed ID: 15375210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis.
    Ewing C; Scorpio A; Nelson DR; Mather TN
    J Clin Microbiol; 1994 Mar; 32(3):755-8. PubMed ID: 8195390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectivity of the highly transformable BBE02- lp56- mutant of Borrelia burgdorferi, the Lyme disease spirochete, via ticks.
    Jacobs MB; Norris SJ; Phillippi-Falkenstein KM; Philipp MT
    Infect Immun; 2006 Jun; 74(6):3678-81. PubMed ID: 16714602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi.
    Iyer R; Hardham JM; Wormser GP; Schwartz I; Norris SJ
    Infect Immun; 2000 Mar; 68(3):1714-8. PubMed ID: 10678995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi.
    Lin YH; Chen Y; Smith TC; Karna SLR; Seshu J
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891543
    [No Abstract]   [Full Text] [Related]  

  • 28. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmid requirements for infection of ticks by Borrelia burgdorferi.
    Strother KO; Broadwater A; De Silva A
    Vector Borne Zoonotic Dis; 2005; 5(3):237-45. PubMed ID: 16187892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi.
    Jewett MW; Lawrence K; Bestor AC; Tilly K; Grimm D; Shaw P; VanRaden M; Gherardini F; Rosa PA
    Mol Microbiol; 2007 Jun; 64(5):1358-74. PubMed ID: 17542926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
    Ohnishi J; Piesman J; de Silva AM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.
    Norris SJ; Carter CJ; Howell JK; Barbour AG
    Infect Immun; 1992 Nov; 60(11):4662-72. PubMed ID: 1398980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
    Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
    Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity.
    Li X; Liu X; Beck DS; Kantor FS; Fikrig E
    Infect Immun; 2006 Jun; 74(6):3305-13. PubMed ID: 16714558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle.
    Grimm D; Eggers CH; Caimano MJ; Tilly K; Stewart PE; Elias AF; Radolf JD; Rosa PA
    Infect Immun; 2004 Oct; 72(10):5938-46. PubMed ID: 15385497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus sequence on the genes encoding the major outer surface proteins (OspA and OspB) of Borrelia garinii isolate.
    Wang J; Masuzawa T; Komikado T; Yanagihara Y
    Microbiol Immunol; 1997; 41(2):83-91. PubMed ID: 9087950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A differential role for BB0365 in the persistence of Borrelia burgdorferi in mice and ticks.
    Pal U; Dai J; Li X; Neelakanta G; Luo P; Kumar M; Wang P; Yang X; Anderson JF; Fikrig E
    J Infect Dis; 2008 Jan; 197(1):148-55. PubMed ID: 18171298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of
    Xiang X; Yang Y; Du J; Lin T; Chen T; Yang XF; Lou Y
    Front Cell Infect Microbiol; 2017; 7():131. PubMed ID: 28473966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.